These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35349833)
21. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance. Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400 [TBL] [Abstract][Full Text] [Related]
22. Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Rao NM; Levine SR; Gornbein JA; Saver JL Stroke; 2014 Sep; 45(9):2728-33. PubMed ID: 25096731 [TBL] [Abstract][Full Text] [Related]
23. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797 [TBL] [Abstract][Full Text] [Related]
24. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator. Ong CT; Wong YS; Wu CS; Su YH Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721 [TBL] [Abstract][Full Text] [Related]
25. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ; Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252 [TBL] [Abstract][Full Text] [Related]
26. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1). Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738 [TBL] [Abstract][Full Text] [Related]
27. Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study. Yu X; Wang Z; Li YV J Thromb Thrombolysis; 2022 Feb; 53(2):291-301. PubMed ID: 34757546 [TBL] [Abstract][Full Text] [Related]
28. Prevalence, risk factors, and clinical outcomes of remote intracerebral hemorrhage after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis. Qiu L; Fu F; Zhang W; He J; Zhan Z; Cheng Z J Neurol; 2023 Feb; 270(2):651-661. PubMed ID: 36198828 [TBL] [Abstract][Full Text] [Related]
29. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase. Tsuruoka A; Atsumi C; Mizukami H; Imai T; Hagiwara Y; Hasegawa Y J Stroke Cerebrovasc Dis; 2014; 23(10):2894-2899. PubMed ID: 25282183 [TBL] [Abstract][Full Text] [Related]
30. GAS6/Axl Signaling Modulates Blood-Brain Barrier Function Following Intravenous Thrombolysis in Acute Ischemic Stroke. Guo ZN; Liu J; Chang J; Zhang P; Jin H; Sun X; Yang Y Front Immunol; 2021; 12():742359. PubMed ID: 34733281 [TBL] [Abstract][Full Text] [Related]
31. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]
32. Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis. Guo Y; Yang Y; Zhou M; He L Stroke Vasc Neurol; 2018 Dec; 3(4):203-208. PubMed ID: 30637125 [TBL] [Abstract][Full Text] [Related]
33. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
34. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450 [TBL] [Abstract][Full Text] [Related]
35. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke. Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233 [TBL] [Abstract][Full Text] [Related]
36. Thrombolytic therapy for wake-up stroke: A systematic review and meta-analysis. Mac Grory B; Saldanha IJ; Mistry EA; Stretz C; Poli S; Sykora M; Kellert L; Feil K; Shah S; McTaggart R; Riebau D; Yaghi S; Gaines K; Xian Y; Feng W; Schrag M Eur J Neurol; 2021 Jun; 28(6):2006-2016. PubMed ID: 33772987 [TBL] [Abstract][Full Text] [Related]
37. Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model. Saguchi T; Onoue H; Urashima M; Ishibashi T; Abe T; Furuhata H Stroke; 2008 Mar; 39(3):1007-11. PubMed ID: 18239172 [TBL] [Abstract][Full Text] [Related]
38. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation. Lei YS; Li H; Lei JY; Li SX; Li DF Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744 [TBL] [Abstract][Full Text] [Related]
39. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Eissa A; Krass I; Bajorek BV J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668 [TBL] [Abstract][Full Text] [Related]
40. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways. Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]